Hypothermia enhances induction of protective protein metallothionein under ischemia by unknown
RESEARCH Open Access
Hypothermia enhances induction of protective
protein metallothionein under ischemia
Youn Hee Park1, Young Mi Lee1, Dong Sun Kim2, Jaechan Park3, Kyoungho Suk4, Jong Kun Kim5*
and Hyung Soo Han1*
Abstract
Background: Hypothermic protection against ischemic stroke has been reported by many studies. Hypothermia is
supposed to mitigate the effects of deleterious genes and proteins and promote the activity of protective genes
and proteins in the ischemic brain. Metallothionein (MT)-1/2 is thought to be a crucial factor for metal homeostasis,
immune function, and apoptosis. This protein was found to exert protective effects in models of brain injury as well.
In the present study, we investigated the effect of hypothermia on MT expression and the underlying mechanisms.
Methods: Cultured bEnd.3 brain endothelial cells were exposed to oxygen glucose deprivation and reperfusion
(OGD+R). Reverse transcription PCR and western blot analyses were performed to measure the expression of MT,
transcription factors, and methylation regulating factors. Transcription factor binding assays were also performed.
Methylation profiles of the promoter area were obtained with pyrosequencing.
Results: Hypothermia protected bEnd.3 cells from OGD+R. When the cells were exposed to OGD+R, MT expression
was induced. Hypothermia augmented MT levels. While OGD+R-induced MT expression was mainly associated with
metal regulatory transcription factor 1 (MTF-1), MT expression promoted by hypothermia was primarily mediated by
the signal transducer and activator of transcription 3 (STAT3). Significantly increased STAT3 phosphorylation at
Ser727 was observed with hypothermia, and JSI-124, a STAT-3 inhibitor, suppressed MT expression. The DNA
demethylating drug 5-aza-20-deoxycytidine (5-Aza) enhanced MT expression. Some of the CpG sites in the promoter
MT=> it should be “the CpG sites in the MT promoter” showed different methylation profiles and some methylation
regulating factors had different expressional profiles in the presence of OGD+R and hypothermia.
Conclusions: We demonstrated that hypothermia is a potent inducer of MT gene transcription in brain endothelial
cells, and enhanced MT expression might contribute to protection against ischemia. MT gene expression is induced
by hypothermia mainly through the STAT3 pathway. DNA methylation may contribute to MT gene regulation
under ischemic or hypothermic conditions.
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Background
Therapeutic hypothermia has been attracting attention
as a method for treating ischemic stroke, traumatic and
other types of brain injury, and cardiac arrest [1-5].
Hypothermia is believed to alter the expression of genes
and proteins involved in cell growth, metabolism, immune
responses, inflammation, cell death, and stress responses
[6-8]. However many studies are still ongoing to clarify
the underlying mechanisms.
Metallothionein (MT)-1/2 is a group of cysteine-rich
and metal binding proteins that play roles in metal
homeostasis, detoxification, and oxygen radical scavenging
[9-11]. Accumulated data indicate that MTs play pro-
tective roles in brain injury models [12-14]. MT has been
detected in ischemic brain [15,16], and our unpublished
data showed increased MT expression in the brain vascu-
lature of a stroke model under hypothermic conditions.
Expression of MT genes is regulated at the transcriptional
level. In the promoter area of MT genes, there are many
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binding sites for different transcription factors [17-20]
such as metal response elements (MREs), glucocorticoid
response elements (GREs), and signal transducer and acti-
vator of transcription (STAT). Metal transcription factor-1
(MTF-1) is one of the major factors regulating MT gene
expression that is essential for transcription by metals
including zinc, and mediates the responses to oxidative
stress and hypoxia [21,22]. MTF-1 binds to MREs, which
are present in six non-identical copies (MRE a through f)
in the 50-flanking region [23]. MTF-1 belongs to the zinc
finger transcription factor family [24].
One study on STAT has shown that lipopolysaccharide
(LPS)-induced activation of STAT1 and STAT3 binding
leads to the activation of MT transcription [25]. STAT3
is continuously expressed in the central nervous system
(CNS) and can be activated by a variety of pathological
stimuli including oxidative stress, cerebral ischemic in-
sults, and cytokines [26-29]. Studies demonstrated that
methylation in the promoter region of the MT gene
contributes to the regulation of the MT gene [30,31].
Expression of this gene is abrogated after treatment with
5-aza-20-deoxycytidine (5-Aza), a compound that stimu-
lates the removal of methyl groups from cytosines of the
CpG island [30,31]. However the impact of MT methyla-
tion under ischemic or hypothermic conditions is unclear.
In the present study, we investigated the induction of
MT gene expression in brain endothelial cells using an
in vitro ischemia model involving oxygen glucose de-
privation (OGD) and reperfusion. Further studies on
transcriptional regulation of the MT gene with ischemia
or hypothermia were also performed. Our goal was to




Immortalized mouse brain endothelial bEnd.3 cells were
purchased from the American Type Culture Collection
(Manassas, VA, USA). The cells were cultured with
Dulbeco’s modified Eagle’s medium (Sigma Chemical, St.
Louis, MO, USA) containing 10% fetal bovine serum
(Sigma Chemical) at 37°Χ in a humidified 5% CO2. The
cells were treated continuously with various concentra-
tions (0, 0.01, and 1 μM) of 5-Aza (Sigma Chemical) for
3 days. Cells were also treated with various concentra-
tions (0, 0.1, 1, and 10 μM) of JSI-124, a STAT3 inhibitor
(Calbiochem, San Diego, CA, USA); 10 μM of U0126, an
inhibitor of MEK1/2 (Cell Signaling, Beverly, MA, USA);
or 1 μM of SB203580, a JNK inhibitor (Cell Signaling)
for 30 minutes before OGD.
Oxygen-glucose deprivation and reperfusion (OGD+R)
Cell cultures were subjected to ischemia-like injury
through OGD for 4 hours by placing cultures in an
anaerobic chamber (Forma, Thermo Scientific, Asheville,
NC, USA) with an atmosphere of O2 tension less than
0.2% (5% CO2, 5% H2, and 90% N2) in a deoxygenated
glucose-free balanced salt solution (BSS0). After 4 hours
of OGD, cultures were reperfused by adding 5.5 mM
glucose to the media at normoxia. Control cultures (no
injury) were incubated with a balanced salt solution con-
taining 5.5 mM glucose (BSS5.5). Cultures were placed
in a humidified 37°C or 33°C incubator depending on
experimental conditions. The cultured cells and media
were harvested at different time points after reperfusion
initiation.
Cell viability assay
To measure cell viability, a non-radioactive cytotoxicity
assay kit (Promega, Madison, WI, USA) was used to de-
tect released lactate dehydrogenase (LDH) in the culture
media. Briefly, 50 μL of the test samples were mixed
with 50 μL of reaction mixture provided by manu-
facturer and incubated for 30 minutes at 25°C while
protected from the light. The absorbance was measured
at 490 nm using a GENius Plus microplate reader
(Tecan, Männedorf, Switzerland). All samples were run
in triplicate.
Reverse transcription PCR
Total RNA was isolated from the cells using Trizol re-
agent (Life Technologies, Rockville, MD, USA) following
the manufacturer’s instructions. For each sample, 2 μg
of total RNA was reverse-transcribed into cDNA with
Oligo(dT)15 primer and M-MLB reverse transcriptase
(Promega) for 90 minutes at 37°C. The products were
amplified using Taq polymerase. β-actin was used as the
internal standard. The sample was heated to 94°C for 2
minutes followed by 27 cycles of denaturation at 94°C
for 1 minute, annealing at 60°C for MT-1 or 55°C for
MT-2 and β-actin for 1 minute, and extension at 72°C
for 1 minute. Amplification was performed in a DNA
thermal cycler (MJ Research, Watertown, MA, USA).
The PCR products were separated in a 2% agarose gel
containing ethidium bromide (Sigma Chemical). The
bands were visualized and photographed using a gel
documentation system (Bio-Rad, Hercules, CA, USA).
In addition to traditional RT-PCR, we also performed
real-time PCR to quantify gene expression. Template
cDNA was added to a PCR master mix containing SYBR
Green (Roche, Manheim, Germany). The master mix
contained HotStarTaq polymerase, which was included
to avoid false positives in the PCR results. GAPDH was
used as an internal control. Real-time quantification of
gene expression was performed using a SYBR-Green
real-time assay with a Roche cycler.
The PCR primer sets were as follows:
Park et al. Journal of Neuroinflammation 2013, 10:21 Page 2 of 15
http://www.jneuroinflammation.com/content/10/1/21
MT-I (159 bp) sense, 50-ACCTCCTGCAAGAAGAGCT
G-30; antisense, 50-GCTGGGTTGGTCCG ATACTA-30
MT-II (209 bp) sense, 50-CCGATCTCTCGTCGATCT
TC-30; antisense, 50-ACTTGTCGGAAGCCTCTT TG-30
β-actin (280 bp) sense, 50-ATCCTGAAAGACCTCTA
TGC-30; antisense, 50-AACGCAGCTCAGTAACAGTC-30
GAPDH (198bp) sense, 50-AACAGCAACTCCCACTC
TTC-30; antisense, 50-CCTCTCTTGCTCAGTGTCCT-30
DNMT1 (240 bp) sense, 50GCTCAAAGACTTGGAA
AGA-30; antisense, 50-AACTGAAAGGGTGTCACTGT-30
DNMT2 (250 bp) sense, 50-CTGCACATGTGGTGG-30;
antisense, 50-ACAGGCTTCTATTGTTTG-30
DNMT3a (256 bp) sense, 50-CTGGAGCTGCAAGAG
TGTCTG-30; antisense, 50-ATGACCGGCACGCTCCAC
GAT-30
DNMT3b (288 bp) sense, 50-TTCGGCTTCCCTGCTC
ACTAC-30; antisense, 50-AGGCTCTGCTCCCACTGAG
CA-30
MBD1 (264 bp) sense, 50-AGAGGAGTGGACAGCAG
TCAC-30; antisense, 50-ATGTAGCCTTGGCAACCAGG
C-30
MBD2 (294 bp) sense, 50-GTCCAGGTAGCAATGAC
GAGA-30; antisense, 50-GCCTCATCTCCACTGTCCA
TG-30
MBD3 (320 bp) sense, 50-CCATTACAGGCCAGCTC
TCTG-30; antisense, 50-AGTCTGCAGCCCAGACTTGG
G-30
MBD4 (280 bp) sense, 50-ATCGGACCTCAGGCAA
GATGG-30; antisense, 50-GTCTTCAGGGTGCACCTG
CTT-30
MECP2 (240 bp) sense, 50-TGAGCCTGAGAGCTCT
GAGGA-30; antisense, 50-CACAGGCTCCTCTCTGTTT
GG-30
Nuclear and cytosolic extraction and electrophoretic
mobility shift assay
Nuclear extracts were isolated from the cultured cells.
The extracts were prepared using a Nuclear Extract Kit
(Active Motif, Carlsbad, CA, USA) according to the
manufacturer’s instructions. The nuclear proteins were
quantified with a Bio-Rad protein assay kit (Bio-Rad).
The DNA-binding activity of MTF-1/MRE was mea-
sured with an electrophoretic mobility shift assay
(EMSA) ‘Gel-Shift’ kit (Panomics, Redwood, CA, USA)
according to the manufacturer’s instructions. The oligo-
nucleotide representing MTF-1 was 50-TTTGCAC
TCGTCTTTGCACTCGTC-30 (core MTF-1 sequence is
shown in bold, Panomics MTF-1/MREd EMSA Probe)
and the oligonucleotide corresponding to MRE was 50-
CTCTGCGCCCGGCCC-30 (core sequence is shown in
bold, Panomics MREa EMSA Probe). Briefly, 1 μg of
poly-(dI-dC) and 10 ng of biotin-labeled MRE probes
were added to 5 μg of nuclear extract and incubated in
binding buffer at 20°C for 30 minutes. The mixture was
then separated in a non-denaturing polyacrylamide gel
and subsequently transferred to Pall Biodyne B nylon
membrane. After blocking, the membrane was incubated
with streptavidin-horseradish peroxidase conjugate at
room temperature for 15 minutes. Band detection was
accomplished with 1X detection buffer provided with
the kit. The shifted bands corresponding to the MTF-1
or MRE/DNA complexes were visualized relative to the
unbound double-stranded DNA after exposing the mem-
brane to X-ray film (Kodak, Toyko, Japan). For the com-
petition experiments, unlabeled double-stranded DNA
probe (cold probe) and mutated-DNA probe were used.
Band density was analyzed with NIH Image J program
(http://rsb.info.nih.gov/ij/).
STAT3 binding assay
STAT3 levels in the cultured nuclear extract were mea-
sured using a TransAM STAT3 kit (Active Motif) to
quantify transcription factor activation. This kit included
a 96-well plate on which oligonucleotide containing the
STAT3 consensus binding site (50-TTCCCGGAA-30) was
immobilized. The active form of STAT3 contained in the
nuclear extract specifically bound to this oligonucleotide.
For this experiment, 5 μg of nuclear extract was used
along with antibody directed against STAT3. A secon-
dary anti-IgG antibody conjugated to horseradish pe-
roxidase (HRP) was then added and absorbance was
measure with a GENius Plus microplate reader (Tecan)
at 450 nM with a reference wavelength of 655 nM. To
evaluate the specificity of the assay, a wild-type consen-
sus oligonucleotide was used as a competitor for STAT3
binding. This oligonucleotide prevented STAT3 from
binding to the probe immobilized on the plate. Add-
itionally, a mutated oligonucleotide was tested and pre-
dicted to have no effect on STAT3 binding.
Western blot analysis
Cells were homogenized in lysis buffer (20 mM Tris–
HCl pH 8.0, 137 mM NaCl, 10% glycerol, 2 mM EDTA,
1% Nonidet P-40, 1 mM Na3VO4, and 5 mM NaF). The
lysates were centrifuged at 12,000 g for 20 minutes at
4°C (Bio-Rad). Proteins in the supernatant were quanti-
fied with a Bio-Rad protein assay kit (Bio-Rad). To
monitor STAT3 phosphorylation, 30 μg of protein were
boiled for 5 minutes at 100°C in gel loading buffer
containing 20% mercaptoethanol and separated in 10%
SDS-PAGE gels. The proteins were transferred to
nitrocellulose membranes (Sigma Chemical) at 90 V
for 90 minutes. The membranes were then blocked
with 5% skim milk (Sigma Chemical) for 1 hour at
room temperature and incubated overnight at 4°C
with primary antibody (1:1000 dilution) against
phosphorylated-STAT3 (Ser727) or total-STAT3 (Cell
Signaling). After washing with PBS, the membranes
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were incubated for 1 hour at room temperature with
HRP-conjugated secondary antibody (1:2000, Santa
Cruz, CA, USA) and then washed again. Proteins in
the membrane were visualized with an ECL system
(Amersham, Piscatway, NJ, USA). The density of each
band was analyzed with NIH Image J program
(http://rsb.info.nih.gov/ij/).
Methylation analysis with pyrosequencing
Genomic DNA was extracted with a Qiagen DNeasy
kit (Qiagen Korea, Seoul, Korea) and treated with so-
dium bisulfite reagent. Briefly, 2 μg of genomic DNA
was denatured by incubating with 2 M NaOH for 10
minutes at 37°C. Next, the denatured DNA was
treated with freshly prepared 10 mM hydroquinone
Figure 1 Protective effect of hypothermia and induction of metallothionein (MT) gene expressions by hypothermia. (A) Lactate
dehydrogenase (LDH) activity in the culture media was measured after bEnd.3 cells were subjected to 4 hours of oxygen glucose deprivation
(OGD) and 24 hours of reperfusion (R) at 37°C or 33°C. LDH levels increased by OGD+R were diminished by hypothermia. Experiments were
performed in triplicate. (B) Total RNA was isolated from bEnd.3 cells cultured in the normal control state, after 4 hours of OGD, and 3 to 24 hours
after reperfusion initiation at 37°C or 33°C. The induction of MT expression peaked after OGD and decreased to basal levels during reperfusion.
Hypothermia-augmented MT expression compared to normothermia. β-actin was used as the internal control. Band densities of the MT gene are
expressed as the mean ± S.E.M. of five experiments. *P <0.05 compared to the control; #P <0.05 compared to normothermia. (C) MT protein
expression was measured by western blot analysis. MT protein expression was induced after OGD and slowly declined during reperfusion. The
level was higher with hypothermia. Band densities are expressed as the mean ± S.E.M. of five experiments. *P <0.05 compared to the control; #P
<0.05 compared to normothermia.
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and 3 M sodium bisulfate (pH 5.0). The sample was
amplified by PCR, and PCR products were cloned
into a pGEM-T easy vector using the pGEM-T easy
vector systems (Promega) according to the manu-
facturer’s protocol. Plasmid DNA was purified with
a Wizard™ DNA purification system (Promega) and
the DNA sequences of several independent clones
were analyzed (Bionics, Seoul, Korea). Briefly, the
PCR reactions were performed with one biotiny-
lated PCR primer, which enabled the conversion of
the PCR product into a single-stranded DNA tem-
plate suitable for pyrosequencing. Confirmation of
PCR product quality and freedom from contamination
was established by separation in 2% agarose and eth-
idium bromide staining. Pyrosequencing was carried
out using the PSQ96MA system (Biotage, Uppsala,
Sweden) according to the manufacturer’s protocol and
single-strand binding protein (PyroGold reagents). All
primer sets were designed with the help of PSQ assay
design software (Biotage) and the sequencing primers
were manually checked for mis-priming sites. In
addition, negative controls were run on the PSQ96MA
instrument to check for background generated from the
sequencing primers, biotinylated primers, or the template
(MT-I F - GGGGAAAGTATTATAGGGATATG, R -
Biotin-AAAACAACCTACCCTCTTTATAAT, S- GAAA
GTATTATAGGGATATGATG).
Figure 2 Delayed protection by hypothermia. We measured the
effect of delayed hypothermia using an lactate dehydrogenase
(LDH) assay. The protective effect of hypothermia was progressively
reduced as the time of hypothermia initiation was delayed 3, 6, and
12 hours (R(+3), R(+6), and R(+12)). However, hypothermia still
offered significant protection when the initiation of hypothermia
was delayed up to 12 hours. Values represent the mean ± S.E.M. of
three different experiments. *P <0.05 compared to 4 hours of
oxygen glucose deprivation (OGD) and 24 hours of reperfusion
(R + 0) at 37°C; #P <0.05 compared to 4 hours of OGD and 24 hours
of reperfusion at 33°C.
Figure 3 Effects of metallothionein (MT) knock-down or overexpression on the cell death after ischemic insult. (A) We measured the
lactate dehydrogenase (LDH) levels in culture media harvested from cells treated with siRNAs (10 nM) targeting MT-1 or −2 after 4 hours of
oxygen glucose deprivation (OGD) and 24 hours of reperfusion at 33°C. *P <0.05 compared to 4 hours of OGD and 24 hours of reperfusion
without siRNA treatment at 37°C; #P <0.05 compared to 4 hours of OGD and 24 hours of reperfusion without siRNA treatment at 33°C.
Suppression of MT gene expression by siRNA was confirmed by measuring the level mRNA using RT-PCR. GAPDH was used as an internal
standard. (B) We measured LDH levels in culture media harvested from the cells treated with MT overexpression vectors (2, 10, and 20 μg) after 4
hours of OGD and 24 hours of reperfusion at 37°C. Values represent the mean ± S.E.M. of three different experiments. *P <0.05 compared to 4
hours of OGD and 24 hours of reperfusion without MT overexpression vector at 37°C. Overexpression of the MT gene by the vector-containing
human MT-1 clone was confirmed by detecting the levels of mRNA (RT-PCR) and protein (western blot) in different conditions: Without MT-1
vector and transfection reagent (CON), transfection reagent only (NC), MT-1 vector in transfection reagent (hMT). GAPDH was used as an
internal standard.
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Figure 4 Effects of ischemia or hypothermia on DNA binding activity. (A) Electrophoretic mobility shift assay (EMSA) analysis of metal
regulatory transcription factor 1 (MTF-1) or metal response elements d (MREd) binding activity was performed using nuclear extract proteins from
the normal control, after 4 hours of oxygen glucose deprivation (OGD), and 3 hours after reperfusion at 37°C or 33°C. MTF1-DNA complexes were
formed by incubating the biotin-labeled MREd probe with different nuclear extract proteins. The mixture was then separated in a non-denaturing
polyacrylamide gel. The shifted bands (arrow) corresponding to the MTF-1/DNA complexes were visualized relative to the unbound double-
stranded DNA. Competition experiment was performed as follows: a. OGD-stimulated sample with labeled MTF-1 probe. b. OGD-stimulated
sample with cold and labeled MTF1 probe. c. Dexametasone-stimulated sample with labeled MTF-1 probe. DNA binding activity increased after
OGD with both normothermia and hypothermia. DNA binding activity is expressed as mean ± S.E.M. of four experiments. *P <0.05 compared to
the control. (B) EMSA analysis of MREa binding activity. A competitive experiment was performed as follows: a. Positive control with labeled
control probe. b. Positive control with labeled probe and cold probe. c. OGD-stimulated sample with labeled MRE probe. d. OGD-stimulated
sample with cold and labeled MRE probe. e. Dexametasone-stimulated sample with labeled MRE probe. MRE binding activity was increased by
both ischemia and hypothermia. Binding activity is expressed as the mean ± S.E.M. of four experiments *P <0.05 compared to the control; #P
<0.05 compared to normothermia. (C) STAT3 binding activity was measured using a STAT3 transcription factor assay kit. Hypothermia increased
the binding of STAT3. Binding activity is expressed as the mean ± S.E.M. of four different experiments. *P <0.05 compared to the control; #P <0.05
compared to normothermia.
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Overexpression and knockdown of the MT gene
We measured the protective effect of MT using an MT
overexpression plasmid vector [14]. Briefly, full-length
human MT-I cDNA (186 bp) originally cloned into a
pDNR-LIB vector was purchased from Life Technologies
Korea (Seoul, Korea). Human MT-I cDNA was amplified
by PCR with primers containing BamHI and XhoI re-
striction enzyme sites, digested with the restriction
enzymes, and then ligated into a pcDNA3.1 plasmid
containing a CMV promoter. This plasmid construct
was sequenced at Solgent Co. (Daejeon, Korea) to verify
the sequences. After transfection of bEnd.3 endothelial
cells with the overexpression vectors (DNA concentra-
tion of 2, 10, and 20 μg in 4 μL of PolyMAG reagent
(Magnetofection, Chemicell GMBH, Berlin, Germany))
for 48 hours, the increased MT expression was con-
firmed with RT-PCR and western blot analyses. The pro-
tective effect against OGD+R was measured using an
LDH assay. MT-1 and MT-2 siRNA were purchased
from Qiagen Korea. After treatment to bEnd.3 endothe-
lial cells with siRNA targeting MT-1 (10 nM) or MT-2
(10 nM) in 3.5 μL of RNAiMAX reagent (Life Technolo-
gies Korea, Seoul, Korea) for 24 hours, the reduction of
MT mRNA levels was confirmed with RT-PCR and the
deleterious effect against hypothermia was measured
using an LDH assay.
Statistical analysis
All experiments were performed in triplicate or more.
Data are presented as the mean ± S.E.M. Comparisons
between groups were made using Sigma-Stat software
(SPSS, Inc., Chicago, IL) and analyzed with a one-way
ANOVA followed by post hoc comparisons. P values
<0.05 were considered statistically significant.
Results
Hypothermic protection against ischemic insult by MT
To investigate the cytotoxic effect of OGD+R and pro-
tective effect of hypothermia, cellular injury was evalu-
ated by measuring the levels of released LDH. At 37°C,
LDH concentration increased after OGD+R. However,
increases of LDH were not observed at 33°C even 6
hours after reperfusion (Figure 1A). These data indicate
that hypothermia protected brain endothelial cells from
ischemic insult. To evaluate the delayed effect, hypo-
thermia was induced after the initiation of reperfusion.
The protective effect of hypothermia was progressively
reduced as the time of hypothermia initiation was delayed.
However, hypothermia still offered significant protection
when initiation was delayed up to 12 hours (Figure 2).
Hypothermic enhancement of MT gene expression
To determine the effect of hypothermia on MT gene
expression, MT mRNA levels were measured with RT-
PCR. MT gene levels with normothermia were increased
after 4 hours of OGD and 3 hours of reperfusion. These
levels returned to baseline after 24 hours of reperfusion.
Hypothermia augmented the increased MT gene expres-
sion (Figure 1B). MT protein levels were measured by
western blot analysis. Under normothermic conditions,
increased MT protein levels were observed after 4 hours
of OGD as well as 3 and 6 hours of reperfusion. After 24
hours of reperfusion, the protein levels of MT decreased.
With hypothermia, MT protein levels were higher at 6
and 24 hours of reperfusion compared to the normo-
thermic group (Figure 1C). We speculate that increased
mRNA expression might have resulted in higher protein
levels observed with hypothermia. To confirm the protect-
ive effect of MT against ischemic insult, we performed
experiments using siRNA and an MT overexpression
vector. Reduced induction of MT gene expression by
siRNA attenuated the protective effect of hypothermia. In
contrast, MT gene overexpression resulted in protection
of endothelial cells against OGD insult with normother-
mia (Figure 3).
DNA binding of MTF-1
We determined whether the transcription factor MTF-1
is involved in the regulation of MT gene expression after
ischemic insult or hypothermia. MTF-1 binds to a site
present in the proximal promoter of the MT genes in re-
sponse to intracellular heavy metal exposure [32,33], re-
active oxygen species [34], and hypoxia [35]. MTF-1
binding to DNA was highly increased by 4 hours of
OGD and returned to basal levels during reperfusion.
Similar responses were observed with hypothermia
(Figure 4A). The binding specificity was confirmed using
unlabeled DNA probe or cold probe (Figure 4A, compe-
tition experiment b).
DNA binding of MRE
In addition to MTF-1, we observed the binding activity
of another MRE probe containing an MREa core se-
quence (50-TGCGCCC-30). The binding activity was in-
creased after OGD exposure at 37°C. With hypothermia,
MREa binding activity was significantly higher than that
observed with normothermia both in the control and
OGD groups (Figure 4B). Competitor MRE oligonucleo-
tide confirmed the specificity (Figure 4B, competition
experiment b).
DNA binding activity of STAT3
STAT3 is a well-known transcription factor that binds to
non-MRE sites of the MT gene promoter area. No sig-
nificant change was found after ischemic insult at 37°C.
However, OGD+R caused increased STAT3 binding in
the hypothermic group (Figure 4C). Competition assays
were performed in order to demonstrate the STAT3
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binding specificity. HepG2 nuclear extract provided in
the assay kit was used as a positive control for STAT ac-
tivation. Competition assays were performed with the
competitor oligonucleotide, a wild-type or mutated
STAT consensus binding site (data not shown).
STAT3 phosphorylation
It is known that phosphorylated STAT3 binds to gene
promoters and regulates the transcriptional activity of
target genes. It has also been reported that increased
STAT3 phosphorylation is accompanied by increased
synthesis of MT in the presence of myocardial ischemia
reperfusion injury [36]. In the present study, STAT3
phosphorylation (Ser 727) was measured using nuclear
extracts from bEnd.3 cells. Western blot analysis demon-
strated that STAT3 phosphorylation was significantly in-
creased after 4 hours of OGD with hypothermia while
no change in the level of phosphorylated STAT3 was ob-
served under normothermic conditions (Figure 5A). This
increase of STAT3 phosphorylation concurs with the
binding activity assay data and implies that STAT3 plays
a temperature-dependent role in the regulation of MT
gene transcription.
Effect of STAT3 inhibition
To confirm whether the STAT3 signaling pathway influ-
ences MT gene expression, we used JSI-124 (also known
as cucurbitacin I) as a STAT3 inhibitor. JSI-124 is a po-
tent and highly selective inhibitor of the JAK/STAT3
pathway [37]. MT-I gene expression was increased by
OGD+R while treatment with JSI-124 (0.1 and 1 μM)
significantly reduced the level of MT gene expression
(Figure 5B). Neither U0126 (an ERK inhibitor) or
SB203580 (a JNK inhibitor) affected MT transcription
(data not shown).
Effect of DNA demethylation on MT gene expression
DNA methylation at position 5 of the cytosine in CpG
dinucleotides is the most significant epigenetic mechan-
ism that leads to altered transcription of target genes
[31]. It was also reported that MT-1 promoter methyla-
tion causes MT gene silencing in cancer cells [38,39].
Thus, methylation of the MT promoter region may be
related to gene expression under various conditions such
as ischemia or hypothermia. We first treated bEnd.3
cells with 5-Aza, a demethylating agent, for 3 days to re-
duce gene methylation. The cells were then exposed to
OGD+R and mRNA levels were measured with RT-PCR.
MT expression was barely detected in the control group.
Treatment with 5-Aza (1 μM) increased in MT levels
even without OGD+R. Furthermore, 5-Aza treatment in-
creased the induction of MT gene expression in a dose-
dependent manner after OGD+R (Figure 6).
Methylation profiles of the MT promoter region
Since our data suggested that MT gene transcription is
affected by DNA methylation under normal or OGD+R
conditions, we determined the precise methylation status
of putative CpG sites in the MT promoter area. After bi-
sulfite treatment, pyrosequencing was performed on
genomic DNA isolated from bEnd.3 cells. The sequence
analyzed in this study corresponded to the proximal pro-
moter region spanning from −300 to +1 of the mouse
MT-1 gene. Sequence analyses of the selected region re-
vealed 29 CpG sites and some of those sites overlapped
the transcription factor binding sites (Figure 7A).
Under normothermic conditions, there were six CpG
sites, demonstrating differences in methylation profiles ob-
served under control and OGD+R conditions (Figure 7B).
Among these six sites, the STAT and MTF-1 binding sites
or MREd were known to be transcription factor binding
areas. As shown in Figure 7B, CpG islands were in a semi-
methylated state under normal conditions while these
islands in cells stimulated with OGD+R were more
demethylated. The overall percentages of methylation
were 62.4 ± 7.1% (control at 37°C), 50.5 ± 5.3% (OGD at
37°C), and 38.4 ± 3.4% (OGD+R at 37°C). Both STAT and
MTF-1 binding sites are more demethylated after OGD+R
(Figure 7B).
With hypothermia, there were four CpG sites, demon-
strating differences in methylation profiles observed
during the control and OGd+R conditions (Figure 7C).
Among these four sites, MREe and MTF-1 binding sites or
MREd were known to be transcription factor binding area.
In Figure 7C, CpG islands were in a semi-methylated state
under normal conditions while those in cells stimulated
with OGD+R were more demethylated. The overall per-
centages of methylation (Figure 7C) were 45.6 ± 10.1 (con-
trol at 33°C), 38.5 ± 6.2% (OGD at 33°C), and 39.7 ± 4.2%
(OGD+R at 33°C). Both the MREe and MTF-1 binding
(See figure on previous page.)
Figure 5 Effect of hypothermia on signal transducer and activator of transcription 3 (STAT3) phosphorylation and effect of a STAT3
inhibitor. (A) Western blot analysis of phosphorylated STAT3 (Ser727) was performed. After 4 hours of oxygen glucose deprivation (OGD),
phosphorylation reached a peak with hypothermia. Relative levels of phosphorylated STAT3 are expressed as the mean ± S.E.M. of three
experiments. *P <0.05 compared to the control; #P <0.05 compared to normothermia. (B) bEnd.3 cells were treated with either vehicle or JSI-124
(0.1 and 1 μM) 30 minutes before OGD. The expression of metallothionein (MT) mRNA was analyzed by reverse transcription polymerase chain
reaction (RT-PCR). JSI-124 inhibited the induction of MT expression. Values represent the mean ± S.E.M. of three different experiments. *P <0.05
compared to the control; #P <0.05 compared to normothermia.
Park et al. Journal of Neuroinflammation 2013, 10:21 Page 9 of 15
http://www.jneuroinflammation.com/content/10/1/21
sites are more demethylated after OGD+R. Demethylated
transcription binding sites following OGD+R might be
associated with the induction of MT expression and
increased transcription factor binding activities.
When the normothermic control group was compared
to the hypothermic control group, 13 CpG sites were
found, indicating different methylation profiles. Among
these 13 sites, ten sites were more methylated and three
were less methylated in the hypothermic group. When the
normothermic OGD+R group was compared to the
hypothermic OGD+R group, ten CpG sites were found,
demonstrating differences in methylation profiles. Among
these ten sites, nine sites were more methylated and one
site was less methylated in the hypothermic group. These
findings indicated that hypothermia seems to shift the MT
promoter region to a more methylated state.
Figure 6 Effect of 5-Aza treatment. Cells were treated with 5-Aza (0.01, and 1 μM) for 3 days and then subjected to oxygen glucose
deprivation and reperfusion (OGD+R). RNA extracted from the cells was used for reverse transcription polymerase chain reaction (RT-PCR).
Metallothionein (MT) induction was potentiated by 5-Aza treatment in a dose-dependent manner. Values represent the mean ± S.E.M. of three
different experiments. *P <0.05 compared to 0 uM of 5 Aza; #P <0.05 compared to the control group.
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Effect of ischemia or hypothermia on DNA
methyltransferases and methyl-CpG binding domain
proteins
Since methylation can interfere with the regulation of
MT gene expression, we measured the mRNA levels of
methylation-related proteins including DNA methyl-
transferases (DNMTs) 1, 2, 3, and 4 (Figure 8A) along
with methyl-CpG binding domain proteins (MBDs) 1, 2,
3, and 4 and methyl-CpG binding protein-2 (MECP-2)
using real-time PCR (Figure 8B). In general, the levels
of DNMTs were lower with hypothermia and DNMT1
expression was markedly decreased by OGD+R
(Figure 8A).
Discussion
In the present study, we demonstrated that the expres-
sion of MT genes was induced by hypothermia under is-
chemic conditions. Both mRNA and protein levels were
increased by OGD+R and hypothermia. Since the induc-
tion of MT expression was observed by hypothermia
without ODG+R in our unpublished experiment, both
ischemia and hypothermia seem to be triggers of MT
gene expression. Given that many studies and our own
data provided evidence of the protective effect of MT in
brain injury models [14,40,41], we suggest that MT is a
novel factor that contributes to hypothermic protection.
To further elucidate the molecular mechanism under-
lying MT induction by ischemia or hypothermia, we
evaluated some transcriptional factors and their binding
elements on the MT promoter area. When binding
activities of the transcription factors to the MT pro-
moter area were measured, MTF-1/MREd showed
strong activity after OGD. STAT3 activity was greater
with hypothermia while that of MREa was increased by
both hypothermia and OGD. STAT3 phosphorylation
after OGD was enhanced by hypothermia and inhibition
of the STAT3 pathway reduced MT expression. According
to other reports, MT expression is regulated by several
promoter regions including MREs, antioxidant response
elements (AREs), and inteleukin-6 responsive elements
[17,18,21,35]. The MRE motif is a major site for MTF-1
binding induced by metal ions and other stimuli
[18,21,35]. The mouse MT promoter region contains six
MRE sequences. The MREd sequence is the strongest
among the six MREs [23] and MREa is most active in
response to zinc [42]. Stuart et al. [24] showed that the
inactivation of the internal MREs within direct MRE re-
peats leads to the loss of promoter activity, suggesting that
every MRE copy within the repeats participates in co-
operative rather than independent action. Additionally,
multiple MREs scattered throughout the promoter region
might synergistically interact [42]. Based on our data and
that from others reports, we expect that MT gene regula-
tion is dependent on hypothermia, ischemia and different
types of transcription factors or that binding elements are
synergistically involved depending on the type of stimuli.
In addition to MREs, STATs have been shown to in-
duce MT transcription and the consensus STAT se-
quence (TTN5AA) is present in the MT-I promoter
[25]. STAT activation plays an important role in mediat-
ing transcriptional regulation by cytokines, hormones,
and growth factors [36,43,44]. However, STAT activation
by hypothermia has not been clearly demonstrated.
STATs are activated by phosphorylation on conserved
tyrosine and serine residues. Whereas phosphorylation
of STATs on tyrosine residues regulates dimerization,
serine/threonine phosphorylation is believed to influence
nuclear translocation and DNA binding activity [45]. As
expected, we demonstrated that hypothermia increased
STAT3 binding activity and serine 727 phosphorylation.
However, STAT3 binding activity was not altered in the
normothermic group. Our results are consistent with
those from other reports showing that STAT binding ac-
tivity does not change after ischemia or reperfusion in a
rat middle cerebral artery occlusion model [16]. Never-
theless, one in vivo study found that STAT3 activation
protects the myocardium from ischemia-reperfusion in-
jury through MT [46]. We are not certain whether this
discrepancy is due to differences between cell types or
other factors. In the present study, JSI-124 treatment
significantly suppressed the induction of MT expression.
This inhibitor is known to exert an inhibitory effect on
STAT3 DNA binding and STAT3 mediated gene tran-
scription [37]. Blaskovich et al. [37] demonstrated that
JSI-124 is highly selective for JAK/STAT3 and does not
affect other pathways such as those mediated by Ras,
Akt, Erk1/2, or JNK. When cells were treated with
U0126 (a MEK1/2 inhibitor) or SB203580 (a JNK
(See figure on previous page.)
Figure 7 Effect of ischemia or hypothermia on methylation profiles of the 50-regulatory region of the metallothionein 1 (MT1)
promoter. (A) Partial sequences of the 50-regulatory region of the mouse MT1 is based on Gene Bank nucleotide sequence [GenBank: J00605].
Twenty-nine CpG sites are marked in red. Some transcriptionally active binding elements such as metal response elements (MRE), signal
transducer and activator of transcription (STAT), and antioxidant response elements (ARE) are shown in blue. (B) Methylation profiles of the
normothermia control and normothermia oxygen glucose deprivation and reperfusion (OGD+R) were compared. (C) Methylation profiles of the
hypothermia control and hypothermia OGD+R were compared. Bisulfite pyrosequencing analysis was performed for 29 CpG sites near the
transcription initiation site of the 50-regulatory region. Methylated status of the CpG sites is expressed as an open circle (○) for unmethylated and
a black circle (●) for methylated.
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inhibitor), no effect on MT induction was observed. We
therefore concluded that that the action of JSI-124 we
observed is specific for the STAT3 pathway.
DNA methylation is a major mechanism that regulates
cell-specific gene expression since CpG methylation in
the promoter region abrogates transcription factor bind-
ing [47]. It is known that chromatin conformation medi-
ates the accessibility of DNA elements to transactivators
such as transcription factors and is critical for the
methylation-dependent transcriptional inhibition. Given
that the epigenetic regulation of MT gene expression has
been reported [30,31], we investigated the possibility of
methylation-dependent regulation under our experimen-
tal conditions by treatment with 5-Aza. Since MT gene
expression was induced by 5-Aza, we hypothesized that
MT gene expression during ischemia or hypothermia is
related to DNA methylation in the MT promoter region.
By performing bisulfite pyrosequencing of the MT-I
gene promoter region, we obtained detailed methylation
profiles.
After ischemic insult was applied, a reduced methylated
or under-methylated state was observed regardless of
temperature. This suggests that ischemic stimuli activate
many genes through release of methylation-dependent
transcriptional inhibition factors as we expected. We can
easily hypothesize that hypomethylation will lead to
enhanced expression of the MT gene similar to that found
after ischemic insult. When we inspected the methylation
profile associated with hypothermia, the CpG sites in the
MT promoter region after hypothermia were more meth-
ylated compared to normothermic conditions. Only the
MREa site was in a reduced methylation state after
hypothermia. Even though the general methylation profile
was not consistent with MT induction, the MREa methy-
lation state concurred with binding activity assay results
and induced MT expression.
Figure 8 Effect of ischemia or hypothermia on methylation regulating factors (A). We measured the mRNA levels of methylation related
proteins such as DNA methyltransferases (DNMTs) 1, 2, 3, and 4 using real-time PCR. RNA was harvested from cells exposed to 4 hours of oxygen
glucose deprivation (OGD) and to reperfusion for 3 to 24 hours. (B) The levels of methyl-CpG binding domain proteins (MBDs) 1, 2, 3, and 4
along with methyl-CpG binding protein-2 (MECP-2) were measured using the same samples and analysis tools as in 6A. Values represent the
mean ± S.E.M. of three different experiments.
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Contrary to our expectations, the STAT area was more
methylated with hypothermia. One study reported that
demethylation of 10 to 20% of the CpG islands in the
promoter is adequate to induce MT-I gene expression
with cadmium or zinc in mouse lymphosarcoma cells
[48]. It has also been shown that MTF-1 binding to
MREa is affected by methylation status, but in the case
of MREd this is unaffected by DNA methylation in vitro
[49]. Therefore, it is likely that MTF-1 binding to MREs
is differentially modulated by methylation status. From
these data, we conclude that although DNA methylation
plays a key role in gene transcription, CpG methyla-
tion alone was not sufficient to regulate MT gene trans-
cription in our experimental model. It seems that both
promoter methylation and transcription factor activity
contribute to the regulation of gene expression.
Our study provides evidence of methylation-dependent
gene regulation following ischemia or hypothermia. Since
both stimuli were applied for short periods of time (within
the range of hours), we suggest that epigenetic control by
methylation can be achieved even in short-term condi-
tions in addition to long-term conditions. To identify the
causes of methylation profile changes by ischemia or
hypothermia, we observed alterations of some methylation
regulating factors such as DNMTs and methyl-CpG bind-
ing proteins including MBDs or MECP-2. The levels of
DNMTs were generally lower with hypothermia. In par-
ticular, DNMT1 expression was markedly decreased by
OGD+R with hypothermia. Since DNMT1 is the most
abundant DNA methyltransferase and considered to be
the key methyltransferase in mammalian cells, lower levels
of DNMT1 might be related with changes in the deme-
thylation state observed under OGD+R conditions. Even
though we could not clearly identify correlations between
changes in the levels of these proteins and methylation
patterns, we expect that more information will be ob-
tained in upcoming studies.
Conclusions
In summary, we demonstrated that MT expression was
markedly increased under hypothermic conditions using
an in vitro ischemia model. Our findings can explain, at
least in part, the protective role of hypothermia. The in-
duction of MT expression was mediated by altered bind-
ing activity of transcription factors such as MTF-1 and
STAT3. In addition, DNA methylation contributed to
MT gene regulation. Our findings provide new insight
for understanding the molecular mechanisms underlying
the ability of hypothermia to protect against ischemia.
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